Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02765737 · ClinicalTrials.gov registry record · NA
Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.
A NA study, sponsored by MiMedx Group.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02765737 is a NA study that was terminated before completion, run by MiMedx Group. The registered enrollment target is 23 participants.
The verdict
NCT02765737, a NA study, was terminated before completion, sponsored by MiMedx Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Multicenter, prospective, randomized, controlled feasibility trial to determine the safety and effectiveness of Dehydrated Human Amnion Chorion Membrane (dHACM) plus Control as compared to Control alone for the treatment of second degree burns (partial thickness burns) as assessed by time to healing and scarring
Interventions
- DEVICE Mepilex Ag
- OTHER Dehydrated Human Amnion/Chorion Membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02765737
The ClinicalTrials.gov registry entry for NCT02765737 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mepilex Ag is the first listed.
NCT02765737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02765737 about?
NCT02765737 is a clinical study titled "Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.". Multicenter, prospective, randomized, controlled feasibility trial to determine the safety and effectiveness of Dehydrated Human Amnion Chorion Membrane (dHACM) plus Control as compared to Control alone for the treatment of second degree burns (partial thickness burns) as assessed by time to healing...
What is the current status of trial NCT02765737?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2016-04. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02765737?
The interventions under investigation include: Mepilex Ag (DEVICE), Dehydrated Human Amnion/Chorion Membrane (OTHER).
Who is sponsoring clinical trial NCT02765737?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.